EXAGEN INC. AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENTInvestors’ Rights Agreement • August 23rd, 2019 • Exagen Inc. • Services-medical laboratories • Delaware
Contract Type FiledAugust 23rd, 2019 Company Industry JurisdictionTHIS AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT (this “Agreement”) is made as of July 12, 2019, by and among Exagen Inc., a Delaware corporation (the “Corporation”), and the persons listed on Schedule A hereto (the “Holders”).
EXAGEN DIAGNOSTICS, INC. FIFTH AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENTInvestors’ Rights Agreement • February 17th, 2016 • Exagen Diagnostics Inc • Services-medical laboratories • Delaware
Contract Type FiledFebruary 17th, 2016 Company Industry JurisdictionTHIS FIFTH AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT (this “Agreement”) is made as of January 19, 2016, by and among Exagen Diagnostics, Inc., a Delaware corporation (the “Corporation”), and the persons listed on Schedule A hereto (the “Holders”).
EXAGEN DIAGNOSTICS, INC. FOURTH AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENTInvestors’ Rights Agreement • September 19th, 2014 • Exagen Diagnostics Inc • Services-medical laboratories • Delaware
Contract Type FiledSeptember 19th, 2014 Company Industry JurisdictionTHIS FOURTH AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT (this “Agreement”) is made as of October 4, 2013, by and among Exagen Diagnostics, Inc., a Delaware corporation (the “Corporation”), and the persons listed on Schedule A hereto (the “Holders”).